Skip to main
RAPP
RAPP logo

Rapport Therapeutics Inc (RAPP)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy RAPP Stock

About Rapport Therapeutics Inc (RAPP)

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Market cap$554.77M
Yesterday's volume199.91K
Revenue (TTM)
Avg. daily volume175.68K
EBITDA (TTM)-$92.14M
Open$14.46
Price / earnings ratio-6.90x
Yesterday's range$14.1 - $15.22
Debt / equity2.74x
52 week range$6.43 - $29.74
5 year debt / equity0.43x
Beta (LTM)1.42x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio31.01x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

RAPP Stock Rating

What analysts recommend for RAPP stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 22, 2025, the market cap for RAPP stock is $554.77M

The current P/E ratio for RAPP stock is -6.9

The 52-week high for RAPP stock is $29.74. The current RAPP stock price $undefined is 100.00% below its 52-week high

The 52-week low for RAPP stock is $6.43. The current RAPP stock price $undefined has increased 100.00% from its 52-week low

No, the RAPP stock does not pay dividends to its shareholders

The target price for RAPP stock is $35 based on the average of what a group of analyst think RAPP stock could be worth at a future date. This is not a prediction by Public.com

How to buy RAPP stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in RAPP stock

    Navigate to the Explore page. Then, type RAPP into the search bar. When you see RAPP stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased RAPP stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Rapport Therapeutics Inc Stock Earnings

The value each RAPP share was expected to gain vs. the value that each RAPP share actually gained.

RAPP (RAPP) reported Q1 2025 earnings per share (EPS) of -$0.68, beating estimates of -$0.75 by 9.33%. In the same quarter last year, RAPP's earnings per share (EPS) was $0. RAPP is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$0.82.

Buy RAPP Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.